Trends in Fontan surgery and risk factors for early adverse outcomes after Fontan surgery: The Australia and New Zealand Fontan Registry experience Ajay J. Iyengar, MBBS(Hons), BMedSci, David S. Winlaw, MBBS(Hons), MD, FRACS, John C. Galati, BSc, PhD, David S. Celermajer, MBBS, PhD, DSc, MSc, FAHA, FRACP, FAA, Gavin R. Wheaton, MBBS, FRACP, Thomas L. Gentles, MBChB, FRACP, Leeanne E. Grigg, MBBS, FRACP, Robert G. Weintraub, MBBS, FRACP, Andrew Bullock, MBBS, FRACP, Robert N. Justo, MBBS, FRACP, Yves d'Udekem, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 2, Pages 566-575 (August 2014) DOI: 10.1016/j.jtcvs.2013.09.074 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Probability of early mortality against age at Fontan, obtained by means of fractional polynomial regression. Dashed lines indicate upper and lower 95% confidence limits. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 566-575DOI: (10.1016/j.jtcvs.2013.09.074) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Surgical progression and early outcomes. AP, Atriopulmonary; LT, lateral tunnel; ECC, extracardiac; pts, patients; ECMO, extracorporeal membrane oxygenation; VAD, ventricular assist device; BCPS, bidirectional cavopulmonary shunt. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 566-575DOI: (10.1016/j.jtcvs.2013.09.074) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions